Columns

Analytical Services | Laboratory Testing

The Great Diaspora of the Pharma Industry

Or, good things come in small(er) packages

Emil W. Ciurczak, DoraMaxx Consulting 11.14.18

“Clinically Speaking”

Let’s get back to what it means to do things “clinically”

Ben Locwin 11.14.18

Injectables | Parenterals

Injectables Go Deeper

Generic majors set sights on complex sterile injectables

S. Harachand, Contributing Editor 11.14.18

Finding Your “Inner Leader”

Leadership is a lifelong journey. What type of leader are you?

Ryan Raver, PhD Contributing Editor 11.14.18

Quality Builds Trust

Beyond compliance, a quality approach to serialization builds trust with partners and end-users

Tim Wright, Editor 11.13.18

Biologics, Proteins, Vaccines | Clinical Trials

Getting to First-in-Human Clinical Trials

A make-or-break milestone for small biopharmas

David Kenyon, Patheon 10.10.18

R&D

Strategic Discovery

CROs top offerings with biology skills.

S. Harachand , Contributing Editor 10.10.18

Analytical Services | Laboratory Testing

Possibly Time for a New Paradigm

Or, why the chicken should cross the road

Emil W. Ciurczak, DoraMaxx Consulting 10.10.18

No, Your Neighbors and Facebook Friends Don’t Know Anything About Health and Wellness

And by the way, get your flu shot

Ben Locwin 10.10.18

Regulatory Affairs

Reporting CPPs to FDA

Importance of identifying critical process parameters in original submissions to FDA.

Aloka Srinivasan, Ph.D. Lachman, Consultant Services 10.10.18

Limited by Labels

How others see you has a lot to do with the brand you’ve built

David G. Jensen, Contributing Editor 10.10.18

Marrying Suppliers & Sponsors!

The 17th Annual Contract Pharma Conference & Exhibition was another huge success

Tim Wright, Editor 10.10.18

An “All-You-Can-Eat” Buffet for Excellence

Or, touching on almost all editorial subjects for the month

Emil W. Ciurczak, DoraMaxx Consulting 09.11.18

Survival Guide to Managing a Tough Boss

Here are some practical steps one can implement to make it through the difficulties caused by a bad boss.

Ryan Raver, PhD, Contributing Editor 09.11.18

Pharma Future

Where are we now? What’s next?

Ben Locwin 09.11.18

CDMOs and Drug Shortages

A new proposal helps create a manufacturing backstop

Gil Roth, President, Pharma & Biopharma Outsourcing Association 09.11.18

HPAPI Outsourcing Likely to Gain Traction

A number of highly potent drugs will soon fall into the generic domain

S. Harachand, Contributing Editor 09.11.18

Who is Responsible for Manufacturing Technology Innovation?

Pharma’s future lies in putting innovations in the hands of innovators, not the regulators

Girish Malhotra, Contributing Editor 09.11.18

Biopharmaceuticals Outsourcing Slows

Manufacturers are shifting focus

Eric S. Langer, BioPlan Associates 09.11.18